Post a Comment Print Share on Facebook
Featured Pedro Sánchez Vladimir Putin Tribunal Constitucional Feijóo Japón

RELEASE: Sai Life Sciences establishes the GMP Kilo laboratory in Alderley Park, Manchester (UK)

(Information sent by the signatory company).

- 0 reads.

RELEASE: Sai Life Sciences establishes the GMP Kilo laboratory in Alderley Park, Manchester (UK)

(Information sent by the signatory company)

MANCHESTER, England and HYDERABAD, India, March 16, 2023 /PRNewswire/ -- Sai Life Sciences, one of the world's leading Contract Research, Development and Manufacturing Organizations (CRO-CDMOs), today announced the creation of a GMP Kilo laboratory at their Alderley Park facility, Manchester, UK. The new GMP Kilo laboratory will enable Sai Life Sciences to offer supplies of drug substances and intermediates in quantities ranging from gram to kilogram to meet clients' clinical needs at an accelerated rate.

Sauri Gudlavalleti, COO of Sai Life Sciences, stated: "The new laboratory, located closer to our customers, has been created with extensive Good Manufacturing Practice checks and world-class infrastructure. The facilities will be combined with our expertise in pathway exploration, process chemistry and scaling, to help our partners accelerate their drug discovery and development journeys by reducing time to first human clinical trials."

Offered both as a stand-alone facility and as part of an integrated service with its capabilities in India, the laboratory consists of one process stream that includes two vessels up to 35 liters in capacity, with the possibility of adding more streams in the future. . It has associated filtration and drying equipment and is designed to provide a containment level of 1μg/m3. The laboratory also offers analytical method validation and analytical services to support lot release, as well as stability studies to enable rapid submission to regulatory bodies.

Previously, in July 2020, the company had opened a new Process Chemistry R&D Center of Excellence (CoE) in Alderley Park, Manchester, to help accelerate NCE development programs of global innovative customers. Since then, this center has grown to become a trusted partner for many innovative companies around the world, providing high quality chemistry, GMP-free delivery and successful technology transfer to our centers in India for expansion.

Over the past three years, the company has made more than $120 million in investments under its SaiNxt initiative, to increase capacity, expand operations, expand into new geographies, grow its scientific talent base, and raise the overall bar for quality, compliance and performance.

About Sai Life Sciences

Sai Life Sciences is a full-service CRO-CDMO working with innovative pharmaceutical and biotech companies around the world to accelerate the discovery, development and commercialization of complex small molecules. The company has more than 2,600 employees at its facilities in India, the United Kingdom and the United States. Sai Life Sciences is a private company backed by global investors TPG Capital and HBM Healthcare Investments.


View original content: